Your browser doesn't support javascript.
loading
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Capuano, Rocco; Prosperini, Luca; Altieri, Manuela; Lorefice, Lorena; Fantozzi, Roberta; Cavalla, Paola; Guaschino, Clara; Radaelli, Marta; Cordioli, Cinzia; Nociti, Viviana; Boffa, Laura; Ragonese, Paolo; Di Gregorio, Maria; Pinardi, Federica; Torri Clerici, Valentina; De Luca, Giovanna; Gajofatto, Alberto; Paolicelli, Damiano; Tortorella, Carla; Gasperini, Claudio; Solaro, Claudio; Cocco, Eleonora; Bisecco, Alvino; Gallo, Antonio.
Afiliação
  • Capuano R; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy/Neurology Unit, Department of Medical Sciences, San Giovanni di Dio and Ruggi d'Aragona, Salerno, Italy.
  • Prosperini L; S. Camillo-Forlanini Hospital, Rome, Italy.
  • Altieri M; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Lorefice L; Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Fantozzi R; IRCCS Neuromed, Pozzilli, Italy.
  • Cavalla P; Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Torino, Turin, Italy.
  • Guaschino C; MS Center, ASST Valle Olona, Gallarate Hospital, Gallarate, Italy.
  • Radaelli M; Department of Neurology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Cordioli C; Montichiari Hospital, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Nociti V; Centro Sclerosi Multipla, Fondazione Policlinico Universitario "A. Gemelli," IRCCS, University Cattolica del Sacro Cuore, Rome, Italy.
  • Boffa L; Tor Vergata Hospital, Rome, Italy.
  • Ragonese P; Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.
  • Di Gregorio M; Neurology Unit, Department of Medical Sciences, San Giovanni di Dio and Ruggi d'Aragona, Salerno, Italy.
  • Pinardi F; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy.
  • Torri Clerici V; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan, Italy.
  • De Luca G; Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
  • Gajofatto A; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Paolicelli D; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro," Bari, Italy.
  • Tortorella C; S. Camillo-Forlanini Hospital, Rome, Italy.
  • Gasperini C; S. Camillo-Forlanini Hospital, Rome, Italy.
  • Solaro C; CRRF Mons. Luigi Novarese, Vercelli, Italy.
  • Cocco E; Binaghi Hospital, Azienda Tutela della Salute (ATS) Sardegna, Cagliari, Italy.
  • Bisecco A; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Gallo A; Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
Mult Scler ; 29(7): 856-865, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37165941
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article